(Q34013831)

30 July 2017

1 reference

title

Cardiovascular risk in diabetes: a brief review (English)

1 reference

30 July 2017

1 reference

Marks JB

1

1 reference

PubMed ID

10959073

30 July 2017

Raskin P

series ordinal

2

1 reference

30 July 2017

1 March 2000

1 reference

Journal of Diabetes and its Complications

30 July 2017

1 reference

30 July 2017

14

1 reference

30 July 2017

108-115

1 reference

30 July 2017

2

1 reference

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Sudden death, impaired glucose tolerance, and diabetes in Japanese American men.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Risk factors for ischaemic heart disease: is it time to measure insulin?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Insulin and Cardiovascular Disease: Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Management of dyslipidemia in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Diabetes and decline in heart disease mortality in US adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Drug treatment of lipid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Evolving natural history of coronary artery disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

The U.K. Prospective Diabetes Study. A review.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900065-9

7 January 2021

10.1016/S1056-8727(00)00065-9

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10959073